Last viewed:
ABT
Prices are updated after-hours
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
(0.0% 1d)
(-2.9% 1m)
(4.9% 1y)
(0.0% 2d)
(0.3% 3d)
(-2.0% 7d)
(NaN%
volume)
Earnings Calendar: 2024-01-24
Market Cap: $ 183,756,016,205
http://www.abbott.com
Sec
Filling
|
Patents
| 107000 employees
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
cardiovascular
nutrition
heart
optical
brands
diagnostics
add to watch list
Paper trade
email alert is off
Press-releases
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
Published: 2024-04-17
(Crawled : 12:00)
- biospace.com/
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
| 0.58%
| O: -0.59%
H: 0.0%
C: 0.0%
results
Pelthos Therapeutics Establishes Board of Directors
Published: 2024-04-16
(Crawled : 15:00)
- biospace.com/
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
| 0.29%
| O: -0.29%
H: 0.0%
C: 0.0%
SVRA
|
$4.96
-3.88%
-4.03%
2.1M
|
Health Technology
| 2.38%
| O: -0.79%
H: 6.0%
C: 3.2%
INSM
|
$26.18
0.12%
0.11%
1.2M
|
Health Technology
| -2.5%
| O: 0.19%
H: 0.41%
C: -2.68%
therapeutics
STD Testing Market Projected to Reach $14.11 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-13
(Crawled : 04:20)
- prnewswire.com
HOLX
|
$74.91
-0.27%
-0.27%
1.7M
|
Health Technology
| Email alert
Add to watchlist
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
| Email alert
Add to watchlist
TMO
|
News
|
$547.25
-1.32%
-0.02%
1.6M
|
Health Technology
| Email alert
Add to watchlist
report
reach
market
AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12
(Crawled : 14:30)
- biospace.com/
PRGO
|
$30.04
0.27%
0.0%
780K
|
Health Technology
| -4.22%
| O: -0.13%
H: 0.0%
C: -2.94%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
| -4.15%
| O: -1.65%
H: 0.0%
C: 0.0%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
| -2.01%
| O: -1.06%
H: 0.21%
C: -1.05%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
| -3.24%
| O: -3.02%
H: 0.0%
C: 0.0%
drug
label
astrazeneca
expansion
for
kids
Toxicology Testing Market size is set to grow by USD 32.58 billion from 2024-2028, High regulatory compliance in food industry boost the market, Technavio
Published: 2024-04-11
(Crawled : 02:00)
- prnewswire.com
WAT
|
$304.18
-3.04%
0.0%
610K
|
Health Technology
| -6.78%
| O: 1.5%
H: 0.23%
C: -1.07%
TMO
|
News
|
$547.25
-1.32%
-0.02%
1.6M
|
Health Technology
| -3.95%
| O: 0.07%
H: 0.0%
C: 0.0%
DGX
|
$126.98
-0.35%
-0.18%
890K
|
Health Services
| -3.8%
| O: -0.13%
H: 0.2%
C: -1.71%
LH
M
|
$199.97
-0.97%
0.0%
680K
|
Health Services
| -3.47%
| O: -0.61%
H: 0.02%
C: -0.68%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
| -1.76%
| O: 0.43%
H: 0.3%
C: -0.18%
food
set
market
Consumer Healthcare Market, 33% of Growth to Originate from North America, Technavio
Published: 2024-04-10
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
| -2.26%
| O: -100.0%
H: NaN%
C: Infinity%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
| -4.76%
| O: -0.64%
H: 0.0%
C: 0.0%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
| -1.76%
| O: 0.43%
H: 0.3%
C: -0.18%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
| -3.19%
| O: 0.05%
H: 0.0%
C: 0.0%
growth
Former QuidelOrtho CEO Douglas Bryant Joins Board of Directors of Vital Biosciences
Published: 2024-04-09
(Crawled : 13:00)
- biospace.com/
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
| -1.19%
| O: 0.06%
H: 1.79%
C: 1.67%
ceo
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
| -0.62%
| O: 2.24%
H: 0.0%
C: -0.8%
PRGO
|
$30.04
0.27%
0.0%
780K
|
Health Technology
| -4.59%
| O: 0.96%
H: 1.17%
C: 0.16%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
| -5.3%
| O: -0.48%
H: 0.0%
C: 0.0%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
| -1.79%
| O: 0.09%
H: 0.16%
C: -0.7%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
| -2.25%
| O: 0.84%
H: 0.0%
C: 0.0%
for
FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
| -4.15%
| O: -1.77%
H: 0.0%
C: -1.81%
PRGO
|
$30.04
0.27%
0.0%
780K
|
Health Technology
| -4.74%
| O: -0.22%
H: 0.8%
C: 0.06%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
| -7.04%
| O: -1.84%
H: 0.0%
C: 0.0%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
| -0.82%
| O: -0.37%
H: 1.42%
C: 1.37%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
| -5.61%
| O: -3.44%
H: 0.0%
C: 0.0%
fda
for
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03
(Crawled : 13:30)
- biospace.com/
PRGO
|
$30.04
0.27%
0.0%
780K
|
Health Technology
| -4.34%
| O: -0.29%
H: 1.34%
C: -0.64%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
| -8.42%
| O: 0.02%
H: 0.0%
C: 0.0%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
| -2.51%
| O: 0.11%
H: 0.37%
C: -0.77%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
| -3.84%
| O: 0.69%
H: 0.0%
C: 0.0%
fda
drug
schizophrenia
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001415889-24-009864
4
2024-04-02
2024-03-31
Buy
A
323
10486
0001415889-24-009863
4
2024-04-02
2024-03-31
Buy
A
310
3650
0001415889-24-009861
4
2024-04-02
2024-03-31
Buy
A
290
3174
0001415889-24-006422
4
2024-03-05
2024-02-29
Sell
F
8339
70365